4TEEN4 Pharmaceuticals GmbH has a total of 13 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANTHA WEST INC, BIOGEN IDEC INT NEUROSCIENCE GMBH and X4 PHARMACEUTICALS AUSTRIA GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Bergmann Andreas | 11 |
#2 | Andreas Bergmann | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021038078A1 | Therapy guidance and/or therapy monitoring for treatment of shock | |
WO2020128039A2 | Therapy guidance and/or therapy monitoring for a treatment with angiotensin-receptor-agonist and/or a precursor thereof | |
KR20200083509A | DPP3 binding agents directed against and binding to specific DPP3-epitopes and their use in the prevention or treatment of diseases/acute conditions associated with oxidative stress |